Amgen vet Laura Hamill takes commercial reins at Gilead amid executive shakeup
In the latest move in a reshuffle of senior execs among the biggest players in biopharma, Gilead has tapped longtime Amgen vet Laura Hamill to head its commercial team.
Hamill fills a position vacated by the retirement of James Meyers, whose career trajectory was quite similar to hers: He joined Gilead in 1996 as a regional sales director, climbing all the way up to EVP, commercial operations. Hamill had been with Amgen since 2002, most recently serving as SVP, US business operations.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.